BIOREACTOR MARKET EXPANDS TO
If bioremediation technology
were used in just 1% of the hazardous waste industry, then it is
potentially a $10 million industry. There are only a couple of pure
players in the bioremediation market, and they are companies which should
be watched. These companies make and manage their own bioreactor
technology. Bioremediation is also handled by large hazardous waste
management companies as one of their potential technologies. Big players
in the bioreactor business have estimated that 2% of their boioreactors
sold are used for bioremediation. For the market as a whole, there are
many big possibilities on the brink of actuality. Tissue engineering,
artificial organs, gene therapy, the replacement of ascites mice in the
U.S. diagnostic industry - all of these possibilities require bioreactor
technology. In addition, with may drug patents ending in 2000, there has
been a race in the pharmaceutical technology to develop replacements.
Biotechnology companies have developed new technologies which have allowed
them to discover and create a greater number of potential compounds a lot
more efficiently. As for new technology, there are new devices such as
cell production systems as well as technology adapted to make conventional
systems more cost efficient. The devices that have worked in the past have
rarely been patented, but rather replicated by all when the industry found
consumers prefer these systems or technologies. The new cell culture and
hollow fiber devices are showing a red trend towards increased patenting.
This trend may represent an effort among suppliers to demonstrate that
cutting technology is important within this highly regulated industry and
can be useful to consumers.
According to a
soon-to-be-released Business Communications Company, Inc. study,C-086R,
Cell Culture Systems and Conventional Bioreactor Technology, the
worldwide market for all bioreactors was valued at $275 million in 1997
and is projected to increase to $380 million in 2002, representing an
average annual growth rate (AAGR) of 6.6%.
BCC points out that the market for
conventional bioreactors was valued at $100 million in 1997 and is
projected to increase to $136.9 million in 2002, an AAGR of 6.4%.
Suppliers of conventional bioreactor
technology have no fear of being replaced by alternative technologies. One
type of alternative technology that has survived the hype is hollow fiber
reactors. The market sector for hollow fiber is projected to experience
substantial growth over the forecast period. The is sector was valued at
$10 million in 1997 and is projected to increase to $15.6 million in 2002,
an AAGR of 9.3%.
The market for specialty bioreactors was
valued at $3.2 million in 1997 and is forecasted to increase to $4.3
million in 2002, and AAGR of 6%.
The market for cell cultures is
forecasted to grow at an AAGR of 8%, increasing from $2 million in 1997 to
$ 2.9 million in 2002. A new line of products known as cell production or
cell culture systems are emerging. The current mix of commercial cell
culture systems is diverse in nature.
BCC concludes that bioreactor related
devices, namely media bags, were valued at $160 million in 1997 and is
expected to increase to $220 million in 2002, an AAGR of 6.6%. Both are
used for small scale systems and pilot projects, most typically seen in
research and development. It is also important to note that there is a
growing amount of interest in develping media that keeps cells alive
longer and producing optimally. Media seems to be the new area within
bioreactor technology to create cost efficiency.
Total U.S. Bioreactor Market Size and Growth
Source: BCC, Inc.
C-086R Cell Culture
Systems and Conventional Bioreactor Technology
PUBLISHED: October 1997
Data and analysis provided courtesy of
BUSINESS COMMUNICATIONS COMPANY, INC., 25 Van Zant Street, Norwalk, CT
06855, Telephone: (203) 853-4266; ext. 309, Email: email@example.com